Format

Send to

Choose Destination
J Med Chem. 2000 Jul 27;43(15):2775-8.

De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.

Author information

1
Department of Chemistry, Synaptic Pharmaceutical Corporation, Paramus, New Jersey 07652, USA. blagu@prius.jnj.com
PMID:
10956183
DOI:
10.1021/jm000085e
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center